Scholarlink

<p>Colorectal cancer (CRC) remains a major global health challenge owing to its therapeutic resistance and high recurrence rates, underscoring the need for mechanism-based interventions. <i>Strobilanthes cusia</i> (Nees) Kuntze, a medicinal herb traditionally used for inflammatory disorders, contains bioactive diterpenoids and alkaloids with anticancer potential. However, the molecular mechanisms underlying this process in CRC remain unclear. This study evaluated sequential Soxhlet extracts of <i>S. cusia</i> leaves using integrated in-vitro and in-silico methods. Among the n-hexane, chloroform, ethanol, and aqueous fractions, the ethanolic extract exhibited the highest cytotoxicity against HCT-116 and SW-620 CRC cells, with IC<sub>50</sub> values of 54.37 and 77.52&#xa0;µg/mL, respectively. GC–MS analysis identified 13 phytoconstituents, and andrographolide was isolated for the first time from <i>S. cusia</i> and structurally characterized using UV–Visible, FTIR, and NMR spectroscopy. Network pharmacology analysis identified checkpoint kinase 1 (CHEK1) as a central target. Molecular docking revealed favorable binding of andrographolide to CHEK1 (− 6.40&#xa0;kcal/mol), comparable to that of the reference compound (− 6.30&#xa0;kcal/mol), and molecular dynamics simulations confirmed complex stability. In vitro validation demonstrated dose-dependent apoptosis and proliferation inhibition in both cell lines, with significantly lower IC<sub>50</sub> values at 48&#xa0;h (isolated: 10.52 ± 1.91µM; commercial: 8.96 ± 9.35µM) than at 24&#xa0;h. These findings identify CHEK1 as a mechanistically relevant target and support further translational investigation of <i>S. cusia-derived</i> andrographolide in CRC therapy.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Uncovering the potential anti-cancer compounds from Strobilanthes cusia against colorectal cancer through network pharmacology and molecular docking

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年6月15日

查看全文
  • Yogananthan Dhanapal,
  • Duraisamy Sridhar,
  • Sulekha Khute,
  • Paranthaman Subash

摘要

Colorectal cancer (CRC) remains a major global health challenge owing to its therapeutic resistance and high recurrence rates, underscoring the need for mechanism-based interventions. Strobilanthes cusia (Nees) Kuntze, a medicinal herb traditionally used for inflammatory disorders, contains bioactive diterpenoids and alkaloids with anticancer potential. However, the molecular mechanisms underlying this process in CRC remain unclear. This study evaluated sequential Soxhlet extracts of S. cusia leaves using integrated in-vitro and in-silico methods. Among the n-hexane, chloroform, ethanol, and aqueous fractions, the ethanolic extract exhibited the highest cytotoxicity against HCT-116 and SW-620 CRC cells, with IC50 values of 54.37 and 77.52 µg/mL, respectively. GC–MS analysis identified 13 phytoconstituents, and andrographolide was isolated for the first time from S. cusia and structurally characterized using UV–Visible, FTIR, and NMR spectroscopy. Network pharmacology analysis identified checkpoint kinase 1 (CHEK1) as a central target. Molecular docking revealed favorable binding of andrographolide to CHEK1 (− 6.40 kcal/mol), comparable to that of the reference compound (− 6.30 kcal/mol), and molecular dynamics simulations confirmed complex stability. In vitro validation demonstrated dose-dependent apoptosis and proliferation inhibition in both cell lines, with significantly lower IC50 values at 48 h (isolated: 10.52 ± 1.91µM; commercial: 8.96 ± 9.35µM) than at 24 h. These findings identify CHEK1 as a mechanistically relevant target and support further translational investigation of S. cusia-derived andrographolide in CRC therapy.